Sagar Lonial, Paul Richardson, Craig Cole, Asim Farooq, Meghan Berkenstock, Julie Byrne, Sumita Roy-Ghanta, Rachel Rogers, Amy Phillips-Jones, Astrid McKeown, Natalie Afshari. "Belantamab mafodotin (belamaf) ocular events are manageable and reversible with dose modifications guided by standard assessments." Blood, 2025. doi:10.1182/blood-2025-4055